| VEIRX | VIVAX | VEIRX / VIVAX | |
| Total Expense Ratio | 0.18 | 0.17 | 106% |
| Annual Report Gross Expense Ratio | 0.18 | 0.17 | 106% |
| Fund Existence | 24 years | 33 years | - |
| Gain YTD | 6.499 | 13.965 | 47% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 50000 | 3000 | 1,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 63B | 216B | 29% |
| Annual Yield % from dividends | 2.20 | 1.93 | 114% |
| Returns for 1 year | 5.27 | 12.38 | 43% |
| Returns for 3 years | 10.51 | 37.39 | 28% |
| Returns for 5 years | 19.97 | 64.90 | 31% |
| Returns for 10 years | 49.21 | 133.35 | 37% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVDX | 17.91 | 0.29 | +1.65% |
| T-REX 2X Long NVIDIA Daily Target ETF | |||
| BSMC | 35.25 | 0.06 | +0.17% |
| Brandes U.S. Small-Mid Cap Value ETF | |||
| FCTE | 25.40 | -0.02 | -0.08% |
| SMI 3Fourteen Full-Cycle Trend ETF | |||
| AQWA | 19.20 | -0.04 | -0.23% |
| Global X Clean Water ETF | |||
| XBI | 124.98 | -1.32 | -1.05% |
| State Street® SPDR® S&P® Biotech ETF | |||